Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income	$ 27,037	$ 33,827
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of deferred leasing costs	23,881	23,167
Amortization of deferred debt costs	760	760
Compensation costs of stock grants and options	851	1,142
Credit losses on operating lease receivables	2,300	556
(Increase) decrease in accounts receivable and accrued income	(7,915)	1,718
Additions to deferred leasing costs	(5,644)	(581)
Decrease in prepaid expenses	3,784	3,369
Increase in other assets	(1,994)	(3,590)
Increase in accounts payable, accrued expenses and other liabilities	3,881	6,666
Decrease in deferred income	(5,192)	(3,202)
Net cash provided by operating activities	41,749	63,832
Cash flows from investing activities:
Acquisitions of real estate investments	0	(24)
Additions to real estate investments	(10,763)	(7,857)
Additions to development and redevelopment projects	(28,164)	(60,718)
Net cash used in investing activities	(38,927)	(68,599)
Cash flows from financing activities:
Proceeds from notes payable	0	22,100
Repayments on notes payable	(30,293)	(48,715)
Proceeds from revolving credit facility	90,000	36,000
Repayments on revolving credit facility	(3,000)	(35,000)
Proceeds from construction loan	25,977	48,731
Additions to deferred debt costs	(101)	(420)
Proceeds from the issuance of:
Common stock	5,016	13,375
Partnership units	734	1,734
Distributions to:
Common stockholders	(24,639)	(24,145)
Noncontrolling interests	(8,368)	(8,303)
Net cash provided by (used in) financing activities	49,730	(549)
Net increase (decrease) in cash and cash equivalents	52,552	(5,316)
Cash and cash equivalents, beginning of period	13,905	14,578
Cash and cash equivalents, end of period	66,457	9,262
Supplemental disclosure of cash flow information:
Cash paid for interest	21,015	21,186
Increase (decrease) in accrued real estate investments and development costs	(8,769)	3,029
Series C Cumulative Preferred Stock
Distributions to:
Preferred stockholders	0	(3,610)
Series D Cumulative Redeemable Preferred Stock
Distributions to:
Preferred stockholders	(2,296)	(2,296)
Series E Cumulative Redeemable Preferred Stock
Distributions to:
Preferred stockholders	$ (3,300)	$ 0